`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`REGENERON PHARMACEUTICALS, INC.,
`Petitioner,
`
`v.
`
`NOVARTIS PHARMA AG,
`NOVARTIS TECHNOLOGY LLC,
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owners.
`
`
`
`
`
`
`
`
`
`Case IPR2021-00816
`Patent 9,220,631
`
`DECLARATION OF PETRA SCAMBOROVA, PhD, JD
`IN SUPPORT OF MOTION FOR PRO HAC VICE
`ADMISSION UNDER 37 C.F.R. § 42.10
`
`
`
`
`
`
`
`
`
`Regeneron Exhibit 1095.001
`Regeneron v. Novartis
`IPR2021-00816
`
`
`
`
`
`
`
`DECLARATION OF PETRA SCAMBOROVA, PhD, JD IN SUPPORT OF
`MOTION FOR PRO HAC VICE ADMISSION
`
`I, Petra Scamborova, submit the foregoing Declaration.
`
`I, Petra Scamborova, am over eighteen years of age and would be competent
`
`to testify as to the matters set forth herein if called upon to do so.
`
`1. I have been employed as an attorney at Regeneron Pharmaceuticals, Inc
`
`since 2017. I have 15 years of experience as a patent litigator and have
`
`represented clients in numerous complex patent litigation cases in various
`
`U.S. District Courts, the U.S. International Trade Commission and the Patent
`
`Trial and Appeal Board. My biography is attached hereto as Exhibit 1096.
`
`2. I have extensive experience with the subject matter at issue in this
`
`proceeding. I have a Bachelor of Arts in Biochemistry, Master of
`
`Philosophy in Biochemistry, and a Doctor of Philosophy in Molecular
`
`Biophysics and Biochemistry. In addition, since 2017, I have represented
`
`Regeneron in multiple actions relating to the same technology described and
`
`claimed in the patent at issue in this inter partes review proceeding. I have
`
`been involved in numerous patent litigations and have experience with a
`
`variety of complex technologies.
`
`3. I am a member in good standing in the state bars of Connecticut and New
`
`York.
`
`2
`
`Regeneron Exhibit 1095.002
`Regeneron v. Novartis
`IPR2021-00816
`
`
`
`4. I have not been suspended or disbarred from practice before any court or
`
`administrative body.
`
`5. I have never had an application for admission to practice before my court or
`
`administrative body denied.
`
`6. No sanction or contempt citation has been imposed against me by any court
`
`or administrative body.
`
`7. I have read and will comply with the Office Patent Trial Practice Guide and
`
`the Board’s Rules of Practice for Trials set forth in part 42 of 37 C.F.R. §§
`
`11.101 et. Seq. and disciplinary jurisdiction under 37 C.F.R. § 11.19(a).
`
`I declare under penalty of perjury that the foregoing Declaration is true and
`
`correct; and further that these statements are made with the knowledge that willful
`
`false statements and the like are punishable by fine or imprisonment, or both, under
`
`Section 1001 of Title 18 of the United States Code.
`
`Dated: December 22, 2021
`
`/Petra Scamborova/
`Petra Scamborova
`Regeneron Pharmaceuticals, Inc.
`777 Old Saw Mill River Road
`Tarrytown, NY 10591
`914-847-7611
`petra.scamborova@regeneron.com
`
`3
`
`Regeneron Exhibit 1095.003
`Regeneron v. Novartis
`IPR2021-00816
`
`